Paper Details

  1. Home
  2. Paper Details

Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.

Author: AboutalebNahid, AjamiMarjan, FiroozAlireza, JaffaryFariba, Nassiri-KashaniMansour, NilforoushzadehMohamad Ali, Pazoki-ToroudiHamidreza

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Acne is a common skin condition, especially in teenagers. Combining different topical treatments can often improve effectiveness and reduce resistance to treatment. This study looked at the effects of a combination of azelaic acid 5% and clindamycin 2% on mild to moderate acne.
Paper Details　
Original Abstract of the Article :
Acne vulgaris, an inflammatory skin disease with different clinical appearances, is a common problem in most adolescents. It seems that using combinations of topical agents can decrease resistance to the treatment and improve the efficacy. Therefore, we evaluated the effects of azelaic acid (AA) 5% ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3109/15569527.2011.581257

データ提供：米国国立医学図書館（NLM）

Combination of Azelaic Acid 5% and Clindamycin 2% for the Treatment of Acne Vulgaris

This study explores the effectiveness of a topical combination therapy for acne vulgaris, a common skin condition. The authors investigate the effects of a 5% azelaic acid and 2% clindamycin combination on mild-to-moderate acne. The study aims to evaluate the efficacy of this combination therapy in addressing the challenges of acne vulgaris.

Combating Acne: A Topical Duo for Clear Skin

The study explores the potential of combining azelaic acid and clindamycin to treat acne vulgaris. It's like discovering a new and effective way to combat the harsh desert winds that can cause irritation and discomfort: this combination therapy offers a potential solution for managing acne symptoms.

Clear Skin Strategies: Managing Acne with Confidence

This study suggests that a combination of azelaic acid and clindamycin may be an effective treatment option for acne vulgaris. It's like discovering a hidden oasis in the desert: finding a source of relief can make a significant difference in managing this common skin condition. However, it's important to consult with a healthcare professional to determine the appropriate treatment plan and address any potential side effects.

Dr.Camel's Conclusion

This research delves into the promising potential of combining azelaic acid and clindamycin for treating acne vulgaris. It's like discovering a new blend of desert spices that can effectively soothe and heal: this combination therapy offers a potential solution for managing acne symptoms. However, it's important to consult with a healthcare professional to determine the appropriate treatment plan and address any potential side effects.

Date :
  1. Date Completed 2012-03-27
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

21612319

DOI: Digital Object Identifier

10.3109/15569527.2011.581257

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.